A small molecule that blocks fat synthesis by inhibiting the activation of SREBP
BPC 157 promotes healthy tendon and ligament healing by accelerating the growth and spread of fibroblasts, which are cells found in connective tissues that are involved in the creation of collagen
They tend to be more potent and more toxic than naturally occurring cannabinoids, leading most governmental regulatory agencies to consider them illicit, toxic chemicals
To use it, gather the peptides molecular weight from the COA or manufacturer data sheet, input the target dose, and confirm the recommended volume before drawing into the syringe
Side Effects & Safety Injection site reactions mild redness or swelling, resolves quickly (documented in clinical-era adverse-event reports) Flushing brief facial warmth Dizziness mild and transient (uncommon) Headache uncommon, typically mild Favorable safety profile Sermorelin's clinical-era trial record documented a favorable adverse-event profile across its years of approved diagnostic use (Prakash & Bhatt, 2020) No significant drug interactions identified during clinical era Documented exclusion criteria: Clinical protocols documented exclusion criteria including active malignancy (on theoretical concern about growth-promoting effects), pregnancy or breastfeeding, and severe renal or hepatic impairment
